Talaris Therapeutics Inc.

NASDAQ: TALS · Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 10:00 PM

Talaris Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.51M 13.67M 18.61M
Short-Term Investments
227.8M 167.61M 225.36M
Long-Term Investments
36.63M n/a n/a
Other Long-Term Assets
3.26M 111K 104K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
10.54M 4.33M 2.54M
Total Current Assets
268.84M 185.61M 246.51M
Property-Plant & Equipment
267K 7.99M 4.8M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
40.16M 8.1M 4.91M
Total Assets
309M 193.72M 251.42M
Account Payables
3.58M 3.89M 2.56M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
227K 910K n/a
Other Current Liabilities
8.68M 6.67M 5.43M
Total Current Liabilities
8.91M 11.46M 7.99M
Long-Term Debt
17K 1.97M n/a
Other Long-Term Liabilities
23K 224K 626K
Total Long-Term Liabilities
40K 2.2M 626K
Total Liabilities
8.95M 13.66M 8.61M
Total Debt
244K 2.88M n/a
Common Stock
3K 4K 4K
Retained Earnings
-135.26M -164.74M -90.85M
Comprehensive Income
296K -721K -78K
Shareholders Equity
300.05M 180.06M 242.81M
Total Investments
264.43M 167.61M 225.36M